Application of Dermal Equivalent Accelerates the Healing of Thermal Injuries (Experimental Study)
Keywords:
dermal equivalent, multipotent mesenchymal stromal cells, collagen, fibrin, skin thermal injuriesAbstract
N/A Probl Cryobiol Cryomed 2013; 23(3):287–291.References
Grin V.K., Popandopulo A.G., Fіstal E.Ya. et al. Experience of dermal equivalent application in combined treatment of severe burns. Transplantologіya 2004; 7 (3): 270–272.
Popandopulo A.G., Slipchenko I.O., Kazakov G.V. et al. Application of modified dermal equivalent in the treatment of diabetic foot ulcers. Bulletin of Urgent and Recovery Medicine 2003; 4 (3): 489–492 .
Sarkisov D.S., Gluschenko E.V., Tumanov V.P. et al. Experience in application of culture of fibroblasts in the treatment of patients with burns. Voenno-Med Zhurnal 1991; (10): 62–63.
Sarkisov D.S., Fedorov V.D., Gluschenko E.V. et al. Theoretical and practical aspects of the use of cultured fibroblasts in the restoration of the skin. Vestnik Ros Academii Nauk 1994; (6): 6–11.
Krasnodembskaya A., Song Y., Fang X. et al. Antibacterial effect of human mesenchymal stem cells is mediated in part from secretion of the antimicrobial peptide LL-37. Stem Cells 2010; 28: 2229–2238.
Le Blanc K., Mougiakakos D. Multipotent mesenchymal stromal cells and the innate immune system. Nature Reviews 2012; 12: 383–396.
Mei S.H., Haitsma J.J., Dos Santos C.C. et al. Mesenchymal stem cells reduce inflammation while enhancing bacterial clearance and improving survival in sepsis. Am J Respir Crit Care Med 2010; 182: 1047–1057.
Patel A.N., Genovese J. Potential clinical applications of adult human mesenchymal stem cell (Prochymal®) therapy. Stem Cells and Cloning Advances and Applications 2011;4: 61–72.
Prockop D.J., Phinney D.G., Bunnell B.A. Mesenchymal stem cells: methods and protocols. Totowa, NJ: Humana Press, 2008.
Ryan J.M., Barry F.P., Murphy J.M. et al. Mesenchymal stem cells avoid allogeneic rejection. J Inflamm 2005; 2 (8): 1–11.
Waterman R.S., Tomchuck S.L. Henkle, S.L. et al. A new mesenchymal stem cell (MSC) paradigm: polarization into a pro-inflammatory MSC1 or an immunosuppressive MSC2 phenotype. PLoS Onee 2010; 5 (4): e10088.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2020 Dimitri A. Zubov, Roman G. Vasyliev, Angela Ye. Rodnichenko, Pavel P. Klymenko, Lyudmyla I. Ostapchenko
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).